tetrathiomolybdate
Showing 1 - 8 of 8
Triple Negative Breast Cancer, Residual Disease Trial (Tetrathiomolybdate, Capecitabine, Pembrolizumab)
Not yet recruiting
- Triple Negative Breast Cancer
- Residual Disease
- Tetrathiomolybdate
- +2 more
- (no location specified)
Nov 15, 2023
NSCLC Trial in Rochester (Tetrathiomolybdate)
Completed
- Non-Small Cell Lung Cancer
- Tetrathiomolybdate
-
Rochester, New YorkUniversity of Rochester
Jul 17, 2019
Primary Biliary Cirrhosis Trial in Ann Arbor (Tetrathiomolybdate, Placebo)
Completed
- Primary Biliary Cirrhosis
- Tetrathiomolybdate
- Placebo
-
Ann Arbor, MichiganUniversity of Michigan
May 19, 2017
Prostate Cancer Trial in Ann Arbor (Tetrathiomolybdate)
Completed
- Prostate Cancer
- Tetrathiomolybdate
-
Ann Arbor, MichiganThe University of Michigan Comprehensive Cancer Center
Jan 20, 2015
Idiopathic Pulmonary Fibrosis Trial in Ann Arbor (Tetrathiomolybdate)
Completed
- Idiopathic Pulmonary Fibrosis
- Tetrathiomolybdate
-
Ann Arbor, MichiganUniversity of Michigan Health System
Feb 5, 2013
Colorectal Carcinoma Trial in Ann Arbor (Irinotecan, 5-Fluorouracil, Leucovorin)
Completed
- Colorectal Carcinoma
- Irinotecan
- +3 more
-
Ann Arbor, MichiganUniversity of Michigan Cancer Center
Feb 5, 2012
Wilson Disease Trial in Ann Arbor (tetrathiomolybdate, trientine)
Completed
- Wilson Disease
- tetrathiomolybdate
- trientine
-
Ann Arbor, MichiganUniversity of Michigan
May 8, 2006
Carcinoma, Hepatocellular Trial in Ann Arbor (Tetrathiomolybdate)
Completed
- Carcinoma, Hepatocellular
- Tetrathiomolybdate
-
Ann Arbor, Michigan3912 Taubman Center
Jun 23, 2005